Search Results 761-770 of 17183 for Alkaptonuria

  1. Care focused on you - Mayo Clinic

    Share · Tweet. See also. Abdominal aortic aneurysm · Acne · Actinic keratosis · Atrial septal defect (ASD) · Autoimmune pancreatitis · Back pain ...

  2. Systems That May Produce Central Sensitization Syndrome of LBP - Mayo Clinic

    Data will be assessed to determine the effect of these characteristics on the symptoms of low back pain. Future work from this pilot study will include a ...

  3. Publications - Anisleidy Carbo, M.D. - Mayo Clinic

    Carbo A, Gupta M, Tamariz L, Palacio A, Levis S, Nemeth Z, Dang S. Mobile Technologies for Managing Heart Failure: A Systematic Review and Meta-analysis.

  4. Benign Prostatic Hyperplasia Archives - Mayo Clinic News Network

  5. Autoimmune hepatitis - Doctors and departments - Mayo Clinic

    This type of hepatitis happens when the immune system attacks the liver with destructive antibodies. Immune-suppressing medicine is the main treatment.

  6. EP study - Doctors & Departments - Mayo Clinic

    An electrophysiology study can show the cause of irregular heart rhythms and guide treatment. Know when it's done and the risks.

  7. Clinical trials - Gastroenterology and Hepatology

    The purpose of this study is to demonstrate the impact of an Adult Inflammatory Bowel Disease (IBD) learning health system approach that enables patients ...

  8. Progressive supranuclear palsy - Doctors and departments - Mayo Clinic

    Mayo Clinic researchers are working to improve diagnosis and treatment of progressive supranuclear palsy. Specialists trained in movement disorders conduct ...

  9. Monoclonal gammopathy of undetermined significance (MGUS) - Care at Mayo Clinic

    Advanced diagnosis and treatment ... Mayo Clinic specialists have experience in diagnosing MGUS, related cancers and other complications. Their expertise enables ...

  10. A Study to Evaluate the Effectiveness and Safety of CAEL-101 in Patients with Mayo Stage IIIa AL Amyloidosis

    The purpose of this study is to determine if CAEL-101 improves the overall survival in patients with cardiac AL Amyloidosis. Participation eligibility.